These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8033045

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin.
    Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE.
    Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer.
    Hempling RE, Piver MS, Natarajan N, Baker TR, Thompson JM, Hicks ML, Mettlin CJ.
    J Surg Oncol; 1993 Sep; 54(1):38-44. PubMed ID: 8377503
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.
    Piver MS, Lele SB, Marchetti DL, Baker TR, Tsukada Y, Emrich LJ.
    J Clin Oncol; 1988 Jun; 6(6):983-9. PubMed ID: 3373267
    [Abstract] [Full Text] [Related]

  • 6. Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer.
    Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE.
    Eur J Gynaecol Oncol; 1998 Jun; 19(1):5-10. PubMed ID: 9476049
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM, Felip E, Rubio D, Vidal R, Bermejo B, Colomer R, Zanon V.
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [Abstract] [Full Text] [Related]

  • 9. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD, Grosh WW, Burnett LS, Jones HW, Wolff SN, Greco FA.
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.
    Conte PF, Bruzzone M, Chiara S, Sertoli MR, Daga MG, Rubagotti A, Conio A, Ruvolo M, Rosso R, Santi L.
    J Clin Oncol; 1986 Jun; 4(6):965-71. PubMed ID: 3519886
    [Abstract] [Full Text] [Related]

  • 11. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS, Lele SB, Marchetti DL, Baker TR, Emrich LJ, Hartman AB.
    J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ, Lele SB.
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Morris M, Gershenson DM, Burke TW, Kavanagh JJ, Silva EG, Wharton JT.
    Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Importance of clinically prognostic factors in the treatment of advanced ovarian carcinoma].
    Albrecht M, Goepel E, Simon WE, Trams G.
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):482-7. PubMed ID: 2993094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.